SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-152998
Filing Date
2022-05-17
Accepted
2022-05-17 16:06:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d337848ddefa14a.htm DEFA14A 44735
2 GRAPHIC g337848g0517083418578.jpg GRAPHIC 4731
  Complete submission text file 0001193125-22-152998.txt   52349
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38079 | Film No.: 22934476
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences